These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 17560695

  • 1. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
    De Wals P, Coudeville L, Trottier P, Chevat C, Erickson LJ, Nguyen VH.
    Vaccine; 2007 Jul 20; 25(29):5433-40. PubMed ID: 17560695
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effectiveness of serogroup C meningococcal conjugate vaccine: a 7-year follow-up in Quebec, Canada.
    De Wals P, Deceuninck G, Lefebvre B, Boulianne N, De Serres G.
    Pediatr Infect Dis J; 2011 Jul 20; 30(7):566-9. PubMed ID: 21326136
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR, Rosen MM, Zeng W, Yap M, Pwee KH, Ang LW, Shepard DS.
    Vaccine; 2011 Sep 02; 29(38):6686-94. PubMed ID: 21745516
    [Abstract] [Full Text] [Related]

  • 8. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Møller P, Pedersen MK, Kristiansen IS.
    Vaccine; 2006 Jul 17; 24(29-30):5690-9. PubMed ID: 16735083
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease.
    De Wals P, Nguyen VH, Erickson LJ, Guay M, Drapeau J, St-Laurent J.
    Vaccine; 2004 Mar 12; 22(9-10):1233-40. PubMed ID: 15003652
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA.
    Pediatrics; 2005 Jun 12; 115(6):1675-84. PubMed ID: 15930232
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
    Caro JJ, Möller J, Getsios D, Coudeville L, El-Hadi W, Chevat C, Nguyen VH, Caro I.
    BMC Public Health; 2007 Jun 29; 7():130. PubMed ID: 17603880
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
    Lloyd A, Patel N, Scott DA, Runge C, Claes C, Rose M.
    Eur J Health Econ; 2008 Feb 29; 9(1):7-15. PubMed ID: 17333089
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada.
    De Wals P, Zhou Z.
    Pediatr Infect Dis J; 2017 Jul 29; 36(7):e203-e207. PubMed ID: 28027288
    [Abstract] [Full Text] [Related]

  • 18. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination].
    Gutiérrez Rodríguez MA, Ramírez Fernández R, García Gutiérrez J, Moreno Civantos A, Hernando García M, Arce Arnáez A, Sendra Gutiérrez JM, Bueno Vallejos R.
    Rev Esp Salud Publica; 2000 Jul 29; 74(4):397-403. PubMed ID: 11031849
    [Abstract] [Full Text] [Related]

  • 19. Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation.
    De Wals P, Trottier P, Pépin J.
    Vaccine; 2006 Apr 24; 24(17):3500-4. PubMed ID: 16517032
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness analysis of a universal infant immunization program with meningococcal C conjugate vaccine in Brazil.
    de Soarez PC, Sartori AM, de Andrade Lagoa Nóbrega L, Itria A, Novaes HM.
    Value Health; 2011 Dec 24; 14(8):1019-27. PubMed ID: 22152170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.